L-α-Glutamine, N-(2-bromoacetyl)glycyl-N-[3-[[4-[(R)-[[(11β,16α)-11-hydroxy-3,20-dioxo-21-(phosphonooxy)pregna-1,4-diene-16,17-diyl]bis(oxy)]methyl]phenyl]methyl]phenyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

L-α-Glutamine, N-(2-bromoacetyl)glycyl-N-[3-[[4-[(R)-[[(11β,16α)-11-hydroxy-3,20-dioxo-21-(phosphonooxy)pregna-1,4-diene-16,17-diyl]bis(oxy)]methyl]phenyl]methyl]phenyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

L-α-Glutamine, N-(2-bromoacetyl)glycyl-N-[3-[[4-[(R)-[[(11β,16α)-11-hydroxy-3,20-dioxo-21-(phosphonooxy)pregna-1,4-diene-16,17-diyl]bis(oxy)]methyl]phenyl]methyl]phenyl]- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

• L-α-Glutamine, N-(2-bromoacetyl)glycyl-N-[3-[[4-[(R)-[[(11β,16α)-11-hydroxy-3,20-dioxo-21-(phosphonooxy)pregna-1,4-diene-16,17-diyl]bis(oxy)]methyl]phenyl]methyl]phenyl]-
• Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br
• (4S)-4-[2-(2-bromoacetamido)acetamido]-4-{[3-({4-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-11-hydroxy-9,13-dimethyl-16-oxo-8-[2-(phosphonooxy)acetyl]-5,7-dioxapentacyclo[10.8.0.02,?.0?,?.013,1?]icosa-14,17-dien-6-yl]phenyl}methyl)phenyl]carbamoyl}butanoic acid
• (S)-4-(2-(2-Bromoacetamido)acetamido)-5-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-8b-(2-(phosphonooxy)acetyl)-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)phenyl)amino)-5-oxopentanoic acid
• 2344809-82-9
• C44H51BrN3O14P
• ADC LINKER